Compassionate Use of Ubamatamab

Available (expanded access)

Conditions studied: Renal Medullary Carcinoma (RMC), Epithelioid Sarcoma

In brief

Provide Compassionate Use of Ubamatamab

Key facts

Study ID

NCT07502716

Run by

Regeneron Pharmaceuticals

Last updated by the study team

2026-03-31

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.